1. Home
  2. MRUS vs FRSH Comparison

MRUS vs FRSH Comparison

Compare MRUS & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • FRSH
  • Stock Information
  • Founded
  • MRUS 2003
  • FRSH 2010
  • Country
  • MRUS Netherlands
  • FRSH United States
  • Employees
  • MRUS N/A
  • FRSH N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • FRSH EDP Services
  • Sector
  • MRUS Health Care
  • FRSH Technology
  • Exchange
  • MRUS Nasdaq
  • FRSH Nasdaq
  • Market Cap
  • MRUS 4.1B
  • FRSH 3.9B
  • IPO Year
  • MRUS 2016
  • FRSH 2021
  • Fundamental
  • Price
  • MRUS $67.47
  • FRSH $12.84
  • Analyst Decision
  • MRUS Strong Buy
  • FRSH Buy
  • Analyst Count
  • MRUS 13
  • FRSH 15
  • Target Price
  • MRUS $90.92
  • FRSH $20.20
  • AVG Volume (30 Days)
  • MRUS 550.9K
  • FRSH 4.1M
  • Earning Date
  • MRUS 10-30-2025
  • FRSH 11-05-2025
  • Dividend Yield
  • MRUS N/A
  • FRSH N/A
  • EPS Growth
  • MRUS N/A
  • FRSH N/A
  • EPS
  • MRUS N/A
  • FRSH N/A
  • Revenue
  • MRUS $56,228,000.00
  • FRSH $782,097,000.00
  • Revenue This Year
  • MRUS $57.42
  • FRSH $17.03
  • Revenue Next Year
  • MRUS $0.23
  • FRSH $12.79
  • P/E Ratio
  • MRUS N/A
  • FRSH N/A
  • Revenue Growth
  • MRUS 59.77
  • FRSH 19.78
  • 52 Week Low
  • MRUS $33.19
  • FRSH $10.81
  • 52 Week High
  • MRUS $69.20
  • FRSH $19.77
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 58.81
  • FRSH 41.83
  • Support Level
  • MRUS $62.80
  • FRSH $12.70
  • Resistance Level
  • MRUS $67.84
  • FRSH $13.81
  • Average True Range (ATR)
  • MRUS 2.39
  • FRSH 0.43
  • MACD
  • MRUS -0.22
  • FRSH 0.00
  • Stochastic Oscillator
  • MRUS 73.67
  • FRSH 10.29

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

Share on Social Networks: